Client Stories
Sale of VievePharm to Zenex Animal Health India, backed by Multiples Equity
Investec has advised VievePharm on the cross-border sale to Zenex, based in India, backed by Multiples Equity
VievePharm, the Netherlands-based animal nutrition specialist headquartered in Enter, has joined Zenex Animal Health India Private Limited (“Zenex”), one of India’s leading and fastest-growing animal health companies.
This transaction underscores Investec’s strong track record in the global animal health sector and reflects the depth of experience our dedicated animal health team brings to complex, cross-border mandates.
About VievePharm
Founded in 2006 and headquartered in Enter, Netherlands, VievePharm is an animal nutrition specialist that has grown into one of Europe’s leading producers of boluses and complementary feed supplements. The company’s portfolio focuses on preventive health solutions for livestock, with products designed to improve animal health, fertility and productivity.
About Zenex
Zenex operates a diversified portfolio spanning livestock, poultry, and companion animals, offering both synthetic and natural products to meet therapeutic and nutritional requirements. With over €100 million in revenue, Zenex has established a strong domestic presence in India and a growing international footprint across 15+ countries in MENA, ASEAN, and Eastern Europe.
About the deal
VievePharm and Zenex are a natural fit. Both companies are built on the same principles: science-backed products, rigorous quality standards and long-term customer relationships. VievePharm’s expertise in preventive nutrition and bolus technology complements Zenex’s broader therapeutic portfolio, while Zenex’s global scale, distribution network and manufacturing platform give VievePharm the opportunity to expand internationally and continue innovating in preventive animal nutrition.
Together, they form a complete and globally competitive animal health business. One with the portfolio depth, geographic reach and ambition to capitalise on the significant growth opportunities ahead.
Our role
Investec advised VievePharm throughout the entire sell-side process up to closing, including:
- Running a competitive auction process
- Deal structuring
- Price negotiations
- Management of the due diligence process
- Coordination of the legal documentation phase
Investec India’s established relationship with Zenex was pivotal in facilitating this transaction.